Common Contracts
5 similar Indenture contracts by Amryt Pharma PLC, Farfetch LTD, Aegerion Pharmaceuticals, Inc.
FARFETCH LIMITEDIndenture • March 4th, 2021 • Farfetch LTD • Services-business services, nec • New York
INDENTURE, dated as of November 17, 2020, between Farfetch Limited, a Cayman Islands exempted company with limited liability, as issuer (the “Company”), and Wilmington Trust, National Association, as trustee (the “Trustee”).
Pursuant to 17 CFR 229.601(b)(10)(iv), confidential information (indicated by [***]) has been omitted from this exhibit because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed.Indenture • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations • New York
INDENTURE, dated as of September 24, 2019, among Aegerion Pharmaceuticals, Inc., a Delaware corporation, as issuer (the “Company”), Amryt Pharma Holdings plc, a company incorporated in England and Wales with company number 12107859 (to be renamed on or around the date hereof as Amryt Pharma plc) (the “Parent”), Amryt Pharma plc, a company incorporated in England and Wales with company number 05316808 (to be renamed and re-registered on or around the date hereof as Amryt Pharma Holdings Limited) (“Old Parent”), the additional guarantors listed on the signature pages hereto, as guarantors (together with the Parent and Old Parent, the “Guarantors”), and GLAS Trust Company LLC, a limited liability company organized and existing under the laws of the State of New Hampshire, as trustee (the “Trustee”).
Pursuant to 17 CFR 229.601(b)(10)(iv), confidential information (indicated by [***]) has been omitted from this exhibit because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed.Indenture • May 11th, 2020 • Amryt Pharma PLC • Pharmaceutical preparations • New York
INDENTURE, dated as of September 24, 2019, among Aegerion Pharmaceuticals, Inc., a Delaware corporation, as issuer (the “Company”), Amryt Pharma Holdings plc, a company incorporated in England and Wales with company number 12107859 (to be renamed on or around the date hereof as Amryt Pharma plc) (the “Parent”), Amryt Pharma plc, a company incorporated in England and Wales with company number 05316808 (to be renamed and re-registered on or around the date hereof as Amryt Pharma Holdings Limited) (“Old Parent”), the additional guarantors listed on the signature pages hereto, as guarantors (together with the Parent and Old Parent, the “Guarantors”), and GLAS Trust Company LLC, a limited liability company organized and existing under the laws of the State of New Hampshire, as trustee (the “Trustee”).
FARFETCH LIMITEDIndenture • March 11th, 2020 • Farfetch LTD • Services-business services, nec • New York
INDENTURE, dated as of February 5, 2020, between Farfetch Limited, a Cayman Islands exempted company with limited liability, as issuer (the “Company”), and Wilmington Trust, National Association, as trustee (the “Trustee”).
THE GUARANTOR PARTIES HERETOIndenture • July 18th, 2019 • Aegerion Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
INDENTURE, dated as of [closing date], among Aegerion Pharmaceuticals, Inc., a Delaware corporation, as issuer (the “Company”), [New Parent], a company incorporated in England and Wales (the “Parent”), Amryt Pharma plc, a company incorporated in England and Wales (“Old Parent”), the additional guarantors listed on the signature pages hereto, as guarantors (together with the Parent and Old Parent, the “Guarantors”), and [trustee’s legal name], as trustee (the “Trustee”).
